Tvardi Therapeutics, Inc.
- TVRD
- NASDAQ
- Biotechnology
- STAT3 Inhibitors
- Small Molecule Therapies
$1.01
Today −5.61%Quote Oct 16, 2026, 08:00 PM UTC
−37.65%over the last month
Max drawdown −38.7%From 1-month high −38.0%3 months −65.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$13.5M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$8.75
+766.3% from here
Floor
$0.97
4.0% below price
Where the price sits
4 analysts
Analyst range, low to high
$3.00$13.00
- Price $1.01
- Resistance $1.08
- Consensus $8.75
Analysts' average target sits about 766% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TVRDPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
12
Founded
2017